Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment

R. Varshochian; M. Riazi-Esfahani; M. Jeddi-Tehrani; A.-R. Mahmoudi; S. Aghazadeh; M. Mahbod; M. Movassat; F. Atyabi; A. Sabzevari; R. Dinarvand

doi:10.1002/jbm.a.35446

Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment

R. Varshochian, M. Riazi-Esfahani, M. Jeddi-Tehrani, A.-R. Mahmoudi, S. Aghazadeh, M. Mahbod, M. Movassat, F. Atyabi, A. Sabzevari, R. Dinarvand

Research output: Contribution to journal › Journal article › Research › peer-review

93 Citations (Scopus)

Original language	English
Journal	Journal of Biomedical Materials Research. Part A
ISSN	1549-3296
DOIs	https://doi.org/10.1002/jbm.a.35446
Publication status	Published - 2015
Externally published	Yes

Access to Document

10.1002/jbm.a.35446

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

@article{a423a1062d474f2d8afa7df7ada20045,

title = "Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment",

author = "R. Varshochian and M. Riazi-Esfahani and M. Jeddi-Tehrani and A.-R. Mahmoudi and S. Aghazadeh and M. Mahbod and M. Movassat and F. Atyabi and A. Sabzevari and R. Dinarvand",

year = "2015",

doi = "10.1002/jbm.a.35446",

language = "English",

journal = "Journal of Biomedical Materials Research. Part A",

issn = "1549-3296",

publisher = "Wiley",

}

TY - JOUR

T1 - Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment

AU - Varshochian, R.

AU - Riazi-Esfahani, M.

AU - Jeddi-Tehrani, M.

AU - Mahmoudi, A.-R.

AU - Aghazadeh, S.

AU - Mahbod, M.

AU - Movassat, M.

AU - Atyabi, F.

AU - Sabzevari, A.

AU - Dinarvand, R.

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-84940416925&partnerID=MN8TOARS

U2 - 10.1002/jbm.a.35446

DO - 10.1002/jbm.a.35446

M3 - Journal article

SN - 1549-3296

JO - Journal of Biomedical Materials Research. Part A

JF - Journal of Biomedical Materials Research. Part A

ER -

Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment

Access to Document

AUB Link

Other files and links

Cite this